The Watson Perspective

With a $50M state investment and a new White House directive, Texas is pioneering ibogaine research. But can it overcome the drug's risks and legal hurdles?

Newcomer Capital-FORCE makes a strategic entry into the competitive ETF space by acquiring two established IBD-branded funds from Innovator.

With a $100M deal for UK's UDlive, Badger Meter is building a global powerhouse to tackle aging pipes, overflows, and climate change with smart tech.

As Hepsiburada prepares its Q1 results, investors weigh strong growth against mounting losses and fierce competition in Turkey's booming digital market.

The GTM platform's 142 #1 G2 rankings confirm its market leadership, but a closer look at user feedback reveals a debate over cost and data quality.

The Canadian retailer celebrates its milestone not just with deals, but with major investments in local charities, reinforcing its unique community-first model.

With Teyana Taylor at the helm, ESSENCE adds Mara Brock Akil, Nikole Hannah-Jones, and Nina Compton to build a deeper, more immersive 2026 festival.

A new coalition launches to combat regulatory hurdles and data rules in the Indo-Pacific, escalating economic tensions and targeting key Asian markets.

A new fund is funneling investment into rare earth projects outside China, and a Canadian company's inclusion could be a game-changer for the West.

Beztak's entire All Seasons portfolio receives top honors from U.S. News, setting a new benchmark for quality in a booming and competitive market.

Global retailer UNIQLO arrives in Winnipeg, partnering with local businesses to weave its 'LifeWear' philosophy into the city's cultural fabric.

A parent-led company gains a U.S. patent for a diazoxide formulation, offering new hope for managing behavioral symptoms in Prader-Willi syndrome.

A new initiative brings leaders from Pakistan and Kenya to the global stage, tackling the underrepresentation of developing nations in healthcare policy.

The former Hotel AKA Brickell is reborn as a Luxury Collection hotel, featuring a star chef and new design in Miami's fiercely competitive landscape.

AI chipmaker Blaize sees Q1 revenue dip amid global memory shortages but secures a major contract, signaling strong confidence in its hybrid AI strategy.

A new, non-invasive urine test from TOBY, Inc. has received FDA Breakthrough status, challenging blood-based rivals and promising a new era of accessible cancer detection.

Following a €5M cornerstone investment, HealthTech firm Rapid Nutrition hires a top advisory firm to navigate its global expansion and bolster investor confidence.

Two South Korean tech leaders are joining forces to commercialize NPU-integrated hardware, aiming to simplify AI deployment in smart cities and security.

Biotech firm Epitopea adds top expert Dr. Lisa Butterfield, validating its novel RNA vaccine approach targeting hidden cancer antigens for hard-to-treat tumors.

Amid a complex economy, DPC Dash is rapidly expanding, breaking global sales records and winning millions with a unique digital and cultural strategy.